Education Library

William O’Neill, MD, and Alejandro Lemor, MD, compare insurance databases to the cVAD registry and discuss factors that characterize high-risk patients requiring MCS.

Alejandro F. Lemor, MD, disusses A-SMART-EF, a new risk score for predicting outcomes in patients supported with Impella® during PCI.

William O’Neill, MD, defines high-risk PCI and explains how to decide when to use mechanical circulatory support in this short interview.

Michael Galvin describes the 4 major views that make up a full echocardiogram as well as the role of color and spectral Doppler in assessing Impella® position.

Dr. Andreas Götzenich interviews Dr. Benedikt Schrage from Hamburg on the topic "Early left ventricular unloading improves survival in patients with cardiogenic shock undergoing extracorporeal membrane oxygenation (ECMO)".

Prof. Christophe Vandenbriele, MD, urges caution and the need for context when drawing conclusions from retrospective analyses in critically ill patients with cardiogenic shock.

Birgit Markus, MD, discusses data on the impact of Impella® heart pump support on hemodynamics and renal function in patients with cardiogenic shock.

Jürgen Leick, MD, discusses his paper on optimizing patient selection in high-risk protected percutaneous coronary intervention.

Prof. Dr. Christophe Vandenbriele discusses his recently published paper on anticoagulation in patients underoing Protected PCI procedures.

Members of the heart team at Tampa General Hospital discuss their early experience with the Impella RP Flex™ with SmartAssist®.

Prof. Karim Ibrahim discusses his article describing best practices for handling high-risk patients in the cardiac catheterization laboratory.

Roberto Lorusso, MD, Alan Gass, MD, and Evgenij Potapov, MD, discuss topics related to ECpella and LV unloading in this Q&A session from ELSO 2022.

Vasileios Panoulas, MD, discusses a pooled analysis of factors predicting outcomes at 90 days in high-risk PCI patients.

Learn more about the data and differences between part I and part II from the York data analysis.

In the presentation titled “Predictive value of residual SYNTAX score for clinical outcomes after high-risk percutaneous coronary intervention: Evidence from pooled analysis of prospective studies.”